BNTX
BioNTech SE
$92.98
-0.55 (-0.59%)
At close · Jul 9
Market Cap
$23.14B
Shares
252,884,261
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$92.98
Open$93.47
Day$92.36–94.63
52W$79.52–124.00
Avg vol 30d1.0M
Short int2.3M · 0.9% float · 2.8d
Short vol31%
Last earningsSep 30, 2025
DataJan 2020–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Moderate
Market backdrop
VIX 15.8 · calm
Equity put/call 0.57
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−6%
below
Price vs 50-day avg
+1%
above
RSI (14)
52
neutral
MACD trend
Positive
52-week position
30%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+7%
trailing
6-month return
−15%
trailing
YTD return
−2%
this year
Relative strength
−24%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $92 › 200d $99 — 200d above 50d
Institutional flow
Accumulating
8 of 276 funds reported for Jun 30 · net +424.1K sh shares · +1 new
Insider flow
Distributing
Net -$5.5M over 90 days · 100% sells
Short interest
Falling
0.92% of float · ▼ -15.2% MoM · 2.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
276 holders — mid 3-yr range
Squeeze score
61
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
42%
annualized · 1-yr
Max drawdown
−30%
past year
ATR
2.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−6%
Bearish
Price vs 50-day avg
+1%
Bullish
RSI (14)
52
Neutral
MACD trend
Positive
Bullish
52-week position
30%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $92 › 200d $99 — 200d above 50d
Institutional flow
Accumulating
8 of 276 funds reported for Jun 30 · net +424.1K sh shares · +1 new
Insider flow
Distributing
Net -$5.5M over 90 days · 100% sells
Short interest
Falling
0.92% of float · ▼ -15.2% MoM · 2.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
276 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $80
Now $93 · 30%
52-wk high $124
vs 200-day avg -6%
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BNTX
this stock
BioNTech SE
|
$23.14B | -2.3% | — | — | 0.9% |
|
ONC
BeOne Medicines Ltd.
|
$437.67B | -0.6% | +22179.2% | 890.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.19B | +9.5% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.03B | -14.0% | +20.8% | 16.3 | 3.3% |
|
ARGX
Argenx SE
|
$54.85B | +8.2% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BNTX | -1.0% | +7.5% | -14.8% | -0.1% | -2.3% |
| SPY | +0.8% | +2.0% | +8.9% | +0.7% | +10.2% |
| vs SPY | -1.8% | +5.5% | -23.7% | -0.7% | -12.6% |
Key facts
CIK
1776985
CUSIP
09075V102
13F (30d)
14 filings
10 filers
Visit website
Investor relations